-
UN says world must navigate 'reality' of 1.5C overshoot
-
China expands Egypt investments in first Xi visit in a decade
-
Taliban govt defends ban on protest, citing Islamic law
-
Messi departure leaves Argentina facing rebuild after golden era
-
10 missing as Turkish cargo ship sinks after collision off Istanbul
-
Ourbit SuperCEX Launches "Cosmic Wheel Season 3. Oracle Realm" on September 2 with 3M USDT Prize Pool
-
easyMarkets Expands Commodity Offering with 24/7 Gold, Silver and Oil Trading
-
Ebola death toll passes 3,000 in DR Congo: official data
-
Australia defends Pacific climate meeting despite doubts on attendance
-
Hong Kong democracy activist Wong pleads guilty to foreign collusion
-
Iran attacks US sites after American strikes, wedding deaths
-
World record prize winner Romantic Warrior retires from horse racing
-
Stocks drop, yields at three-decade highs on Mideast flare-up
-
5,000 US sailors arrive in Thailand after months at sea
-
EU summons Russian envoy, eyes sanctions after Germany drone 'attack'
-
Joshua Wong, Hong Kong's pro-democracy poster child
-
Stocks drop as yields and oil prices spike on Mideast flare-up
-
Nepal tunnel rescuers seek trapped workers but hit dead ends
-
Cricketers to get best rooms at Asian Games, says Japan chief
-
Zverev wins wild five-setter, Rybakina and Gauff ease through at US Open
-
Zverev out-lasts Sonego in wild five-setter to advance at US Open
-
US energy secretary arrives in Venezuela to discuss oil deal
-
Amid war, Ukrainian soldiers celebrate love at ritual wedding
-
Meloni government becomes Italy's longest-lasting
-
Venice to roll out red carpet for Clooney on opening night
-
Funerals in Nepal for missing, a week after deadly floods
-
Hong Kong democracy activist Wong pleads guilty to foreign collusion: AFP
-
US aircraft carrier arrives in Thailand after months at sea
-
Stocks sink, yields at multi-decade highs and oil spikes on Mideast flare-up
-
US aircraft carrier approaches Thai port after months at sea
-
US defends Trump Venezuela oil deal as energy secretary lands in Caracas
-
Nepal's young PM faces gravest test after flood catastrophe
-
Jubilant Monfils celebrates birthday with US Open win
-
What rainbow? LGBTQ Indonesians on edge as hostility mounts
-
The Japanese idealist behind the last deradicalisation NGO in Somalia
-
O'Connor eyes Wallabies World Cup swansong after Force return
-
Rybakina, Gauff advance as Zverev launches US Open campaign
-
Syria UXO causing death, injury every six hours: charity
-
Macron in Britain to help unveil tapestry, hold Burnham talks
-
Tiger Woods set to change not guilty plea in DUI case: court documents
-
China's Xi to hold talks with Sisi in rare visit to Egypt
-
Zelensky warns airlines Russian skies not safe due to Ukraine drones
-
Confident Gauff reaches US Open 2nd round with straight-set win
-
UK vows anti-settler measures as Israel warns of retaliation
-
US postal whistleblower warns ballot system could disrupt midterms
-
New pro Koivun among US Presidents Cup picks
-
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026
-
Earthwise and Eagle Plains Intersect Gold Mineralization in all Holes at the Iron Range Precious Metals Project, SE BC
-
Preppy Pledges to Help 250,000 People Enter Allied Health Careers by 2031
-
Independent Pharmacy Cooperative Acquires USave Pharmacy Group
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025
WOBURN, MA / ACCESS Newswire / May 6, 2025 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025. The results will be released after the market close on Thursday, May 15 and the company will host a conference call on Friday, May 16 at 10:00am Eastern Time.
Conference Call and Webcast Information
Event: | Biofrontera Inc. First Quarter 2025 Financial Results and Business Update Conference Call |
Date: | Friday, May 16, 2025 |
Time: | 10:00am ET |
Conference Call: | 1-877-877-1275 (U.S.) |
Webcast: | Webcast | First Quarter 2025 Financial Results and Business Update Conference Call |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz ® with the RhodoLED ® lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne. For more information, visit www.biofrontera-us.com and follow Biofrontera on LinkedIn and X.
Contacts:
Investor Relations
Andrew Barwicki
1-516-662-9461
[email protected]
SOURCE: Biofrontera Inc.
View the original press release on ACCESS Newswire
Y.Baker--AT